BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors

  Checkmate Pharmaceuticals, Inc. today announced the addition of Jon Wigginton, M.D. to its Board of Directors (“Board”).

  January 31, 2022

   · 

  6 min read
• Drug Development

  Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)

  Denovo Biopharma LLC today announced that the FDA has authorized the company’s investigational new drug (IND) application of DB104.

  January 31, 2022

   · 

  2 min read
• Biotech Beach

  Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jan 31, 2022

  Cardiff Oncology, Inc. announced that on January 31, 2022, non-qualified stock option awards to purchase an aggregate of 55,008 shares of its common stock were granted to one new employee.

  January 31, 2022

   · 

  2 min read